CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,609,206 | -57.2% | 165,317 | -54.6% | 0.03% | -58.6% |
| Q1 2023 | $13,106,543 | -43.5% | 364,273 | -30.1% | 0.07% | -44.4% |
| Q4 2022 | $23,215,265 | +86.2% | 520,872 | +17.4% | 0.13% | +100.0% |
| Q3 2022 | $12,471,000 | +90.0% | 443,642 | +82.3% | 0.06% | +103.2% |
| Q2 2022 | $6,562,000 | +23.6% | 243,383 | +56.2% | 0.03% | +82.4% |
| Q1 2022 | $5,307,000 | -72.6% | 155,804 | -69.0% | 0.02% | -65.3% |
| Q4 2021 | $19,402,000 | -31.7% | 502,125 | -4.5% | 0.05% | -27.9% |
| Q3 2021 | $28,392,000 | – | 525,867 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |